BAUSCH HEALTH AMERICAS, INC.
A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
- First Posted Date
- 2019-06-17
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT03987763
- Locations
- 🇺🇸
Bausch Site 11, Fountain Valley, California, United States
🇺🇸Bausch Site 05, Spartanburg, South Carolina, United States
🇺🇸Bausch Site 06, Miami, Florida, United States
Steady-State Pharmacokinetics of Rifaximin 550 mg Tablets in Healthy and Hepatically Impaired Subjects
- First Posted Date
- 2019-01-28
- Last Posted Date
- 2023-11-30
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT03818672
- Locations
- 🇺🇸
Valeant Site 01, San Antonio, Texas, United States
Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris
- First Posted Date
- 2018-09-10
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 585
- Registration Number
- NCT03664752
- Locations
- 🇺🇸
Valeant Site 230, Raleigh, North Carolina, United States
🇺🇸Valeant Site 206, San Diego, California, United States
🇺🇸Valeant Site 218, San Diego, California, United States
Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris
- First Posted Date
- 2018-09-10
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 608
- Registration Number
- NCT03664739
- Locations
- 🇺🇸
Valeant Site 130, Pflugerville, Texas, United States
🇺🇸Valeant Site 110, Norfolk, Virginia, United States
🇺🇸Valeant Site 118, Largo, Maryland, United States
Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control Gel
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2019-10-21
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 61
- Registration Number
- NCT03653403
- Locations
- 🇺🇸
Valeant Site 01, Austin, Texas, United States
Efficacy and Safety of Plecanatide in Children 6 to <18 Years of Age With Irritable Bowel Syndrome With Constipation (IBS-C)
- Conditions
- Interventions
- First Posted Date
- 2018-07-24
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 210
- Registration Number
- NCT03596905
- Locations
- 🇺🇸
Synergy Research Site, Newport News, Virginia, United States
A Postmarketing Study of Plecanatide in Breast Milk of Lactating Women Treated With TRULANCE®
- Conditions
- First Posted Date
- 2018-06-11
- Last Posted Date
- 2019-11-22
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT03551873
- Locations
- 🇺🇸
Synergy Research Center 001, Raleigh, North Carolina, United States
🇺🇸Synergy Research Center 002, North Hollywood, California, United States
🇺🇸Syergy Research Center 003, Tamarac, Florida, United States
Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE)
- First Posted Date
- 2018-05-03
- Last Posted Date
- 2023-04-13
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 71
- Registration Number
- NCT03515044
- Locations
- 🇺🇸
Bausch Health Site 03, Boston, Massachusetts, United States
🇺🇸Bausch Health Site 08, Miami, Florida, United States
🇺🇸Bausch Health Site 16, Charleston, South Carolina, United States
Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female Subjects
- Conditions
- Interventions
- First Posted Date
- 2017-10-31
- Last Posted Date
- 2018-05-08
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT03327558
- Locations
- 🇺🇸
Valeant Site 01, San Diego, California, United States
LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2017-08-18
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 3500
- Registration Number
- NCT03254667
- Locations
- 🇺🇸
Registry, Bridgewater, New Jersey, United States